Preoperative predictors of survival after resection of small hepatocellular carcinomas

Annals of Surgery

Volumn 235, Issue 5, 2002, Pages 722-731

  Wayne, Jeffrey D ^a   Lauwers, Gregory Y ^c   Ikai, Iwao ^d   Doherty, Dorota A ^b   Belghiti, Jacques ^e   Yamaoka, Yoshio ^d   Regimbeau, Jean Marc ^e   Nagorney, David M ^f   Do, Kim Anh ^b   Ellis, Lee M ^a   Curley, Steven A ^a   Pollock, Raphael E ^a   Vauthey, Jean Nicolas ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KYOTO UNIVERSITY   (Japan)

^e BEAUJON HOSPITAL   (France)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0036242372     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200205000-00015     Document Type: Article

References (55)

1. Declining cancer rates in the 1990s
2. Rising incidence of hepatocellular carcinoma in the United States
3. Cancer statistics. 2001
4. Treatment of hepatocellular carcinoma
5. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients
6. Is transplantation really superior to resection in the treatment of small hepatocellular carcinoma?
7. Liver transplantation for hepatocellular carcinoma: Prognostic factors associated long-term
8. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis
9. Hepatocellular cancer: Resection or transplantation
10. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
11. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
12. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
13. Hepatectomy for hepatocellular carcinoma: The surgeon's role in long-term survival
14. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value
15. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis
16. An analysis of 412 cases of hepatocellular carcinoma at a Western center
17. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis
18. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma
19. Transection of the oesophagus for bleeding oesophageal varices
20. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
21. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
22. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
23. Histological grading and staging of chronic hepatitis
24. Nonparametric estimation from incomplete observations
25. Regression models and life tables
26. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma
27. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
28. Long-term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features
29. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation
30. Prognostic histologic indicators of curatively resected hepatocellular carcinoma. A multi-institutional analysis of 425 patients with definition of an histologic prognostic index
31. Surgery for small liver cancers
32. Factors affecting longterm outcome after hepatic resection for hepatocellular carcinoma
33. Liver transplantation for hepatocellular carcinoma
34. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
35. Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes
36. Liver transplantation for hepatocellular carcinoma
37. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma
38. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma
39. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma
40. Characteristics of hepatocellular carcinoma in patients with negative virus markers: Clinicopathologic study of resected tumors
41. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma
42. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma
43. A simplified staging for hepatocellular carcinoma
44. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation
45. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients
46. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience
47. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection
48. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
49. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal
50. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma
51. Screening for hepatocellular carcinoma in patients with advanced cirrhosis
52. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation